Assembly Biosciences (ASMB) Gains from Sales and Divestitures (2019 - 2025)
Assembly Biosciences (ASMB) recorded quarterly Gains from Sales and Divestitures of $18855.0 in Q4 2025, down 63.65% quarter-over-quarter from $51872.0 in Q4 2024, and down 63.65% on a YoY basis from $51872.0 in Q4 2024.
Assembly Biosciences (ASMB) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends
Assembly Biosciences' Gains from Sales and Divestitures history runs 7 years deep, the most recent figure standing at $18855.0 for Q4 2025.
- In Q4 2025, Gains from Sales and Divestitures fell 63.65% year-over-year to $18855.0; the TTM figure through Dec 2025 stood at $18855.0 (down 63.65% YoY), while the FY2025 annual figure was $18855.0, down 63.65% from the prior year.
- Gains from Sales and Divestitures was $18855.0 for Q4 2025 at Assembly Biosciences, down from $51872.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $347096.0 in Q4 2021 to a low of $18855.0 in Q4 2025.
- Historically, Gains from Sales and Divestitures has averaged $146093.9 across 5 years, with a median of $135929.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Gains from Sales and Divestitures jumped 52.24% in 2021, then slumped 82.8% in 2023.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $347096.0 in 2021, then retreated by 28.15% to $249376.0 in 2022, then plunged by 82.8% to $42898.0 in 2023, then increased by 20.92% to $51872.0 in 2024, then slumped by 63.65% to $18855.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $18855.0 (Q4 2025), $51872.0 (Q4 2024), and $42898.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,855.00 |
| Dec 31, 2025 | 18,855.00 |
| Dec 31, 2024 | 51,872.00 |
| Dec 31, 2024 | 51,872.00 |
| Dec 31, 2023 | 42,898.00 |
| Dec 31, 2023 | 42,898.00 |
| Dec 31, 2022 | 249,376.00 |
| Dec 31, 2022 | 249,376.00 |
| Sep 30, 2022 | 225,869.00 |
| Sep 30, 2022 | 225,869.00 |
| Jun 30, 2022 | 107,411.00 |
| Jun 30, 2022 | 107,411.00 |
| Mar 31, 2022 | 92,286.00 |
| Mar 31, 2022 | 92,286.00 |
| Dec 31, 2021 | 347,096.00 |
| Dec 31, 2021 | 347,096.00 |
| Sep 30, 2021 | 184,387.00 |
| Sep 30, 2021 | 184,387.00 |
| Jun 30, 2021 | 151,054.00 |
| Jun 30, 2021 | 151,054.00 |